Related by context. Frequent words. (Click for all words.) 71 LY# [002] 64 elotuzumab 64 MORAb 64 investigational compound 63 investigational compounds 62 CRx 61 DISCLOSURE NOTICE 61 Panzem R 61 PEG SN# 60 LY# [003] 60 visit www.oncolyticsbiotech.com 59 Initiates Phase 59 OR SIMILAR STATEMENTS ARE 59 PS# [001] 59 BEMA Buprenorphine 59 CCX# 59 FENTORA 58 Pivotal Phase 58 R sorafenib tablets 58 Phenoptin 58 Oncolytics please 58 tanespimycin 57 Azedra 57 liposomal formulation 57 HGS ETR1 57 Drug Candidate 57 relapsed refractory multiple myeloma 57 deforolimus 57 diabetic neuropathic pain 57 HCV protease inhibitor 57 interferon alfa 57 Pivotal Phase III 57 Presents Positive 57 dipeptidyl peptidase 4 57 INGN 57 VQD 56 PXD# 56 CAUTIONARY NOTE REGARDING FORWARD 56 plus prednisone 56 PLAN OR EXPECT 56 celgosivir 56 orally bioavailable 56 MNTX 56 prostones 56 Completes Enrollment 56 Rebif ® 56 CR# vcMMAE 56 advanced carcinoid 56 luteinizing hormone releasing 56 risks anduncertainties 55 MGCD# [001] 55 Amrubicin 55 forward lookingstatements 55 Legislation Reform Act 55 talactoferrin 55 anticancer compound 55 ISTODAX 55 CONTAINS FORWARD LOOKING STATEMENTS 55 otelixizumab 55 squalamine 55 Epratuzumab 55 Allovectin 7 R 55 Eltrombopag 55 Phase 1b trial 55 registrational trial 55 6R BH4 55 AEZS 55 Icatibant 55 Phase IIa trial 55 Mipomersen 55 Vandetanib 55 Statements Certain 55 Asentar 55 Clinical Trial Results 55 Hsp# inhibitor 55 metastatic hormone refractory 55 valopicitabine 55 SECTION #A OF 55 ALN TTR# 55 Traficet EN 55 RGB # 55 Irinotecan 55 STATEMENTS AND 55 TORISEL 55 MEK inhibitor 54 TOCOSOL Paclitaxel 54 calcineurin inhibitors 54 imatinib mesylate 54 Belinostat 54 Diamyd ® 54 thymalfasin 54 SAFE HARBOR PROVISIONS OF 54 humanized anti 54 KRN# 54 HISTORICAL ARE FORWARD LOOKING 54 AS ESTIMATE ANTICIPATE BELIEVE 54 TREANDA 54 Hsp# inhibitors 54 NKTR 54 IMMU 54 CUDC